Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-22
2005-03-22
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S250000, C544S295000, C544S346000, C544S350000
Reexamination Certificate
active
06869955
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula I:and their use in treating anxiety, depression, and other psychiatric and neurological disorders.
REFERENCES:
patent: 4091219 (1978-05-01), Denzel et al.
patent: 4296114 (1981-10-01), Appleton et al.
patent: 4510141 (1985-04-01), Heckendorn
patent: 4665182 (1987-05-01), Nichol et al.
patent: 4701455 (1987-10-01), Nichol et al.
patent: 5198547 (1993-03-01), Bailey et al.
patent: 5283244 (1994-02-01), Sakamoto et al.
patent: 5424311 (1995-06-01), Billhardt-Troughton et al.
patent: 0 074 929 (1983-03-01), None
patent: 08092250 (1996-04-01), None
patent: 9533727 (1995-12-01), None
patent: 9533750 (1995-12-01), None
patent: 9534563 (1995-12-01), None
J. Rivier et al., Proc. Nat. Acad. Sci., 80:4851 (1983).
W. Vale et al., Science, 213:1394 (1981).
W. Vale et al., Rec. Prog. Horm. Res., 39:245 (1983).
G.F. Koob, Persp. Behav. Med., 2:39 (1985).
E.B. DeSouza et al., J. Neurosci., 5:3189 (1985).
J.E. Blalock, Physiological Reviews, 69:1 (1989).
J.E. Morley, Life Science, 41:527 (1987).
E.B. DeSouza, Hosp. Practice, 23:59 (1988).
C.B. Nemeroff et al., Science, 226:1342 (1984).
C.M. Banki et al., Am. J. Psychiatry, 144:873 (1987).
R.D. France et al., Biol. Psychiatry, 28:86 (1988).
M. Arato et al., Biol. Psychiatry, 25:355 (1989).
C.B. Nemeroff et al., Arch. Gen. Psychiatry, 45:577 (1988).
P.W. Gold et al., Am J. Psychiatry, 141:619 (1984).
F. Holsboer et al., Psychoneuroendocrinology, 9:147 (1984).
P.W. Gold et al., New Eng. J. Med., 314:1129 (1986).
R.M. Sapolsky, Arch. Gen. Psychiatry, 46:1047 (1989).
Grigoriadis et al., Neuropsychopharmacology, 2:53 (1989).
D.R. Britton et al., Life Sci., 31:363 (1982).
C.W. Berridge and A.J. Dunn, Regul. Peptides, 16:83 (1986).
C.W. Berridge and A.J. Dunn, Horm. Behav., 21:393 (1987).
Brain Research Reviews, 15:71 (1990).
K.T. Britton et al., Psychopharmacology, 86:170 (1985).
K.T. Britton et al., Psychopharmacology, 94:306 (1988).
N.R. Swerdlow et al., Psychopharmacology, 88:147 (1986).
G.F. Koob and K.T. Britton, Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide, E.B. DeSouza and C.B. Nemeroff eds., CRC Press, p. 221 (1990).
Copy of the Partial European Search Report dated Nov. 14, 2003 (EP 03 07 8058).
Guaraldi, G.P., et al., “An open trial of methyltetrahydrofolate in elderly depressed patients,”Study of MTHF in Elderly Depressives,Jun. 1993, 5(2), 101-105.
Ito, T., et al., “Treatment of depression with (6R)-tetrahydrobiopterin, the natural cofactor of tyrosine hydroxylase and tryptophan hydroxylase,”Biogenic Amines,1988, 5(6), 489-493.
Bristol-Myers Squibb Pharma Company
Makujina Shah R.
Raymond Richard L.
LandOfFree
Tetrahydropteridines and pyridylpiperazines for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydropteridines and pyridylpiperazines for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydropteridines and pyridylpiperazines for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3425152